evidence of suppression of the specific antibody response. The levels of specific antibody induced were dependent on the source and number of plastic-adherent cells present in the cultures. We intend to use this model system to study further the basis of immunity to foot-and-mouth disease virus.
Foot-and-mouth disease virus (FMDV) is the causal agent of a highly contagious and economically important disease of cloven-hoofed animals. The infectious particle is a picornavirus with a sedimentation coefficient of 146S and comprises a protein capsid, consisting of 60 copies each of four virally coded polypeptides encapsulating a single-stranded, positive-sense RNA genome.
In many parts of the world where the disease is endemic, inactivated, whole-virus preparations are routinely used to protect livestock. Based on a considerable body of data, there is a generally accepted correlation between the level of circulating, neutralizing antibody and protection against livevirus challenge (9, 19, 22) . For this reason, there is a need for a fundamental understanding of the cellular aspects of immunity to FMDV and, in particular, the mechanisms of B-cell activation and regulation.
Although studies with polyclonal B-cell activators (7, 11) have greatly advanced our understanding of these events, it is generally agreed that such responses may differ considerably from those of specific antigen triggering. In this regard, a number of investigators, notably Mishell and Dutton (18) , have established techniques for studying the in vitro production of antigen-stimulated specific antibodies. Antigens used include erythrocytes (6, 17) , ovalbumin (10) , keyhole limpet hemocyanin (16) , rabies virus (13) , influenza virus (15, 24) , and a rabies virus vaccine (21) .
In this paper, we describe the in vitro induction of an anamnestic antibody response in primed mouse spleen cells by a soluble preparation of FMDV with reference to variables such as antigen concentrations and adherent-cell requirements.
MATERIALS AND METHODS
Preparation of viruses. Sucrose density gradient-purified 146S FMDV was prepared as previously described (5) and further purified by a second sucrose density gradient cycle. Briefly, FMDV strain A24 Cruzeiro was grown in 8-liter cultures of suspended BHK-21 cells, clarified by filtration, and concentrated by precipitation with polyethylene glycol 6000. After removal of fatty materials, the virus was concentrated by high-speed centrifugation and purified on 5 to 30% linear sucrose gradients. The virus peak was identified by its absorption at 260 nm, removed from the gradient, and made * Corresponding author. 0.88% (wt/vol) with NaCl and 50% (vol/vol) with saturated ammonium sulfate. After 2 h at 4°C, the precipitate was recovered by centrifugation at 3,000 rpm for 30 min, dissolved in phosphate-buffered saline (pH 7.6) containing 1% (vol/vol) ox serum, and subjected to a second sucrose density gradient purification. The mass of 146S virus was calculated by using the 1% extinction coefficient at 260 nm (1-cm path length) of 7.6 (3).
In addition to FMDV strain A24 Cruzeiro, purified FMDV strain 01 BFS 1860 was also prepared by this method. Swine vesicular disease virus strain UKG 27/72, grown on glass bead monolayers of IB-RS-2 cells (kindly supplied by J. P. Whiteside, formerly of this Institute), was concentrated and purified by the same procedure except that gradients were formed with sucrose containing 0.3 M rather than 0.15 M NaCl.
Immunization protocol. Groups of 6-to 7-week-old mice from the Pirbright colony of Parkes surgically derived inbred mice were immunized by intraperitoneal inoculation of 10 p.g of live FMDV strain A24 Cruzeiro in 0.2 ml of 50% Freund complete adjuvant. Mice were boosted at 21 and 42 days with 5 ,ug of virus in 0.1 ml of sterile 0.15 M NaCl by intravenous inoculation and left for a further 20 days before use in experiments.
Culture medium. Complete medium consisted of RPMI 1640 (Flow Laboratories) supplemented with 10% fetal calf serum, 2 mM glutamine, 1 mM pyruvate, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), 0.05 mM 2-mercaptoethanol, nonessential amino acids, 100 U of penicillin per ml, and 100 pug of streptomycin per ml.
The fetal calf serum was selected from 17 sera on the basis of three criteria: (i) maintenance of cultures through to secretion of antibody, (ii) optimum resolution of specific and nonspecific stimulations in a blastogenic assay, and (iii) minimal stimulation of an autologous mixed-lymphocyte reaction.
Preparation of spleen cells. Spleens were removed aseptically and prepared individually by the method of Koprowski et al. (13) . Briefly, spleens were passed through a stainless steel mesh, and the cell pulp was collected in cold RPMI 1640 medium. The cells were sedimented by centrifugation at 200 x g for 5 min, and the erythrocytes were lysed with cold aqueous 0.83% (wt/vol) NH4Cl for 5 After the addition of virus or mitogen, 100-,ul samples of culture supernatant were removed daily for the measurement of antibody. On day 0 and at subsequent 2-day intervals, the nonadherent cell population was suspended, and further 10-and 100-,lI samples were removed. These were used for enumeration of viable cells and for a blastogenic assay, respectively. Fresh complete medium was added to replace the losses due to sampling and evaporation. ELISA. Culture supernatants were assayed for total antibody by a sandwich enzyme-linked immunosorbent assay (ELISA) and virus-specific antibody by an indirect ELISA, using the methods described by Abu Elzein and Crowther (1, 2) . Plates were coated with either affinity-purified rabbit immunoglobulin G (IgG) anti-mouse immunoglobulin or strain A24 Cruzeiro virus at 2 FLg/ml and thoroughly washed. After 60 min of incubation with culture supernatants at 370C on an orbital shaker, unbound protein was removed by thorough washing, and bound antibody was detected by a further 60 min of incubation with a dilution of rabbit antimouse IgG-horseradish peroxidase conjugate. Unbound conjugate was removed by washing, and the bound enzyme was detected by addition of substrate. Color development was stopped by the addition of 1.25 M sulfuric acid, and the absorbance at 492 nm was read on a Titertek Multiskan photometer. The results of replicate treatments were averaged.
The specificity of the spleen cell culture antibody for the homologous virus, strain A24 Cruzeiro, was assessed in a competition assay (2) . Briefly, plates were coated with homologous virus, and dilutions of culture antibody were allowed to react with the bound strain A24 virus in the presence of various concentrations of liquid-phase competing antigen. The competing antigens were homologous virus, heterologous FMDV strain 01 BFS 1860, or swine vesicular disease virus strain UKG 27/72. After thorough washing, mouse antibody bound to the solid-phase virus was detected with the anti-mouse conjugate, and the results of replicates were averaged. Percent competition = (AIO -At)/(A100 -AO) x 100, where A100 was the maximum value obtained with antibody only (no competing virus), AO was the minimum value obtained with liquid-phase virus only (no antibody), and At was the value obtained with antibody and either homologous or heterologous competing antigens.
Virus-neutralizing antibody determination. The neutralizing antibody titers of 11-day poststimulation culture supernatants were determined. The assay was performed in 96-well, flat-bottom microtiter plates (Flow Laboratories), using the method described by Golding et al. (8) . medium alone was assessed in a blastogenic assay by the incorporation of [3H]thymidine (Fig. 1A and 1B) . Consistent with their ability to polyclonally activate B and T cells, respectively, LPS and ConA induced major peaks of activity in both the immune and nonimmune cell cultures. In contrast, the FMDV-driven blastogenic response was much weaker and was confined to the immune cell culture. That is, the incorporation of [3H]thymidine by FMDV-treated immune spleen cells was significant at 95% and also at 99% confidence limits (P < 0.01) of the immune cells treated with medium alone and the nonimmune cells treated with either FMDV or medium alone.
In vitro induction of anti-FMDV antibody. Induction of virus-specific antibody was studied in cultures of spleen cells derived from immune mice and treated with FMDV strain A24 Cruzeiro, ConA, LPS, or medium alone. Figure 2A shows the results obtained with nonimmune spleen cells, whereas Fig. 2B shows the results of a typical experiment with immune spleen cells. Of the nonimmune cell cultures, only those stimulated with LPS showed a background of virus-specific antibody which, although higher than for the other treatments, fell within the confidence limits of the medium-only controls. In contrast, significant levels of virus-specific antibody (more than two standard deviations above those of the medium-only controls) were detected in the LPS-and FMDV-stimulated immune spleen cell cultures after 5 and 8 days, respectively, whereas medium and ConAtreated cultures produced only very low levels of specific antibody. That the virus-induced antibody was the product of de novo protein synthesis is shown by the results of an experiment in which cycloheximide, added to the cultures at day 5, abrogated the immune response to the virus (Table 1) .
To date, antibody activity in the FMDV-stimulated culture supernatants has been detected by ELISA In a number of experiments in which FMDV was removed before day 5 of culture, it was found that levels of specific antibody were reduced, although not abrogated. The presence of virus for at least 5 days allowed the development of a maximal antibody response, although a few cultures in which the virus was continuously present failed to reach the maximum. Thus, in some instances the concurrent presence of virus and antibody seemed to modulate the antibody response, presumably through the formation of immune complexes, but did not appear to influence the overall trend.
All of the work reported here was conducted with live virus which was present in the cultures for the duration of the experiment. However, essentially identical results were obtained with virus which had been previously inactivated with 0.05% (vol/vol) acetylethyleneimine (data not shown). Thus, the possibility of replication of virus within a culture affecting antibody induction or production seems unlikely. Furthermore, recent experiments in our laboratory indicate that FMDV does not replicate in leukocytes of murine or bovine origin (unpublished data).
Antigen dose dependency of anti-FMDV antibody response. Antigen dose dependency was examined in spleen cell cultures derived from thrice-immunized or once-immunized (10 ,ug/ml, 0.2 ml intraperitoneally, 50% Freund complete adjuvant) mice. The optimum concentration of the A24 Cruzeiro strain of FMDV was 1 ,ug/ml of culture regardless of the number of immunizations or the method chosen to express the data (Fig. 3) . The use of very low concentrations of virus (0.01 and 0.001 ,ug/ml) resulted in the reduction of specific antibody to levels below that of the medium-only control cultures. In contrast, the total antibody response was not influenced by the concentration of virus present in the culture; that is, the quantity of total antibody produced by the FMDV containing cultures was indistinguishable from that of the medium-only control cultures. Figure 4 shows the results obtained at day 10 and serves to summarize some of the conclusions drawn from Fig. 3 .
Specificity of anti-FMDV antibody. The specificity of the immunizing virus for the antibody produced by the in vitro cultrues was examined by competition ELISA. Figure 5 shows that liquid-phase strain A24 Cruzeiro competed effectively with bound strain A24 Cruzeiro for antibody derived from A24 Cruzeiro-stimulated cultures, whereas the liquidphase heterologous strain, 01 BFS 1860, competed poorly. The failure to compete with the homologous virus was even more pronounced with the unrelated virus, SVDV. When 12S particles prepared by acid degradation of 146S particles of A24 Cruzeiro were used in the competition, they competed relatively poorly on a weight-for-weight basis with whole virus for antibody derived from A24 Cruzeiro-stimulated cultures (data not shown). The specificity of the in vitro immune response for strain A24 Cruzeiro is also indicated by the results in Table 1 . It can be seen that only the homologous virus was successful in stimulating antibody production and that the antibody produced was specific to strain A24 Cruzeiro.
Influence of adherent cells on anti-FMDV antibody response. Adherent cells were removed from the peritoneal exudates and spleens of previously immunized mice by passage on plastic petri dishes for 3 h at 37°C. Nonadherent cells and plate washings were pooled and kept on ice, whereas plastic-adherent cells were recovered by treatment with Lidocaine (4 mg/ml; Sigma) in phosphate-buffered saline (pH 7.6) followed by scraping with a silicone rubber policeman. The recovered cells were washed with ice-cold RPMI 1640 and kept on ice.
Nonadherent cells were further processed to remove mononuclear phagocytes by passage down a Sephadex G10 column, and the effluent was used to prepare cultures as described above. The cultures were then supplemented with different numbers of autologous plastic-adherent cells and 1 ,ug of A24 Cruzeiro virus per ml.
The results (Fig. 6 ) suggest an obligate requirement for plastic-adherent cells in the production of anti-FMDV antibody by the cultures. The highest specific antibody titers were obtained with 20% splenic adherent cells (Fig. 6A) or 5% peritoneal exudate adherent cells (Fig. 6B) . Higher or lower concentrations of adherent cells resulted in reduced antibody production. Since low titers of specific antibody were observed in the cultures that were theoretically free of adherent cells, it is probable that a small number of adherent cells eluded the depletion procedures. This conclusion is supported by several other experiments (data not shown) in (15, 24) and rabies virus (13, 21 Under the experimental conditions employed, there was little difference between spleen cell cultures derived from singly or thrice immunized mice both with respect to the quantity of antibody detected and the concentration of virus required for optimum antibody production. At virus concentrations higher than 1 ,ug/ml, antibody levels were reduced, whereas at very low virus concentrations (less than 0.01 ,ug/ ml) the immune response was apparently suppressed. Studies are in progress to examine this "suppression" with particular reference to (Doel, unpublished data) .
Several experiments indicated the specificity of the in vitro response to the virus and ruled out the possibility that FMDV was activating the cultures polyclonally. The blastogenic response to FMDV was restricted to spleen cells from previously immunized mice, whereas LPS stimulated both immune and nonimmune cells. Both antibody induction and the antibody induced in FMDV-stimulated cultures, as measured by ELISA, were specific to the strain of virus used for in vivo immunization and in vitro stimulation. For reasons given in the results section, it has not been possible to conduct similar specificity experiments in terms of virusneutralizing antibody. In contrast to the specific immune response, the levels of total antibody were not greatly influenced by concentrations of antigen in the range of 0.001 to 10 ,ug/ml.
The in vitro anamnestic response to FMDV was clearly dependent on the presence of plastic-adherent cells which were assumed to be composed largely of macrophages in the case of peritoneal exudate and a mixture of macrophages and dendritic cells in the case of the spleen. This result and the observed inhibitory effect of supraoptimal concentrations of adherent cells were consistent with previously reported data (20) and suggest an important role for adherent cells in the presentation of FMDV antigens and consequent promotion of the immune response.
The work described here will form the basis of further investigations of the cellular basis of immunity to FMDV. Studies are in progress to examine the relative roles of B and T cells and antigen-presenting cells, and it is our intention to attempt primary in vitro stimulation of murine spleen cells to augment the present approach.
